TGF-β signaling in aortic aneurysm: Another round of controversy

Journal of Genetics and Genomics

Volumn 37, Issue 9, 2010, Pages 583-591

  Lin, Fuyu ^a   Yang, Xiao ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

Author keywords

Aneurysm; Mouse model; TGF signaling

Indexed keywords

LOSARTAN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

AORTA ANEURYSM; ARTICLE; GENE ACTIVATION; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANIMALS; AORTIC ANEURYSM; DISEASE MODELS, ANIMAL; HUMANS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 77957685103     PISSN: 16738527     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1673-8527(09)60078-3     Document Type: Article

References (52)

1. Arbustini E., Marziliano N., Magrassi L. Aneurysm syndromes and TGF-β receptor mutations. N. Engl. J. Med. 2006, 355:2155. author reply 2156.
2. Brooke B.S., Habashi J.P., Judge D.P., Patel N., Loeys B., Dietz H.C. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N. Engl. J. Med. 2008, 358:2787-2795.
3. Carta L., Smaldone S., Zilberberg L., Loch D., Dietz H.C., Rifkin D.B., Ramirez F. p38 MAPK is an early determinant of promiscuous Smad2/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice. J. Biol. Chem. 2009, 284:5630-5636.
4. Carvalho R.L., Itoh F., Goumans M.J., Lebrin F., Kato M., Takahashi S., Ema M., Itoh S., van Rooijen M., Bertolino P., Ten Dijke P., Mummery C.L. Compensatory signalling induced in the yolk sac vasculature by deletion of TGFβ receptors in mice. J. Cell Sci. 2007, 120:4269-4277.
5. Charbonneau N.L., Ono R.N., Corson G.M., Keene D.R., Sakai L.Y. Fine tuning of growth factor signals depends on fibrillin microfibril networks. Birth Defects Res. C Embryo Today 2004, 72:37-50.
6. Chaudhry S.S., Cain S.A., Morgan A., Dallas S.L., Shuttleworth C.A., Kielty C.M. Fibrillin-1 regulates the bioavailability of TGFβ1. J. Cell Biol. 2007, 176:355-367.
7. Chen Q., Chen H., Zheng D., Kuang C., Fang H., Zou B., Zhu W., Bu G., Jin T., Wang Z., Zhang X., Chen J., Field L.J., Rubart M., Shou W., Chen Y. Smad7 is required for the development and function of the heart. J. Biol. Chem. 2009, 284:292-300.
8. Choudhary B., Zhou J., Li P., Thomas S., Kaartinen V., Sucov H.M. Absence of TGFβ signaling in embryonic vascular smooth muscle leads to reduced lysyl oxidase expression, impaired elastogenesis, and aneurysm. Genesis 2009, 47:115-121.
9. Daugherty A., Cassis L.A. Mouse models of abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 2004, 24:429-434.
10. Daugherty A., Manning M.W., Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 2000, 105:1605-1612.
11. Deng G.G., Martin-McNulty B., Sukovich D.A., Freay A., Halks-Miller M., Thinnes T., Loskutoff D.J., Carmeliet P., Dole W.P., Wang Y.X. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Circ. Res. 2003, 92:510-517.
12. Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 2003, 425:577-584.
13. Dietz H.C. TGF-β in the pathogenesis and prevention of disease: a matter of aneurysmic proportions. J. Clin. Invest. 2010, 120:403-407.
14. Dietz H.C., Cutting G.R., Pyeritz R.E., Maslen C.L., Sakai L.Y., Corson G.M., Puffenberger E.G., Hamosh A., Nanthakumar E.J., Curristin S.M., Stetten G., Meyers D.A., Francomano C.A. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991, 352:337-339.
15. Doetschman T. Influence of genetic background on genetically engineered mouse phenotypes. Methods Mol. Biol. 2009, 530:423-433.
16. El-Hamamsy I., Yacoub M.H. Cellular and molecular mechanisms of thoracic aortic aneurysms. Nat. Rev. Cardiol. 2009, 6:771-786.
17. Feng X.H., Derynck R. Specificity and versatility in TGF-β signaling through Smads. Annu. Rev. Cell Dev. Biol. 2005, 21:659-693.
18. Frutkin A.D., Otsuka G., Stempien-Otero A., Sesti C., Du L., Jaffe M., Dichek H.L., Pennington C.J., Edwards D.R., Nieves-Cintrón M., Minter D., Preusch M., Hu J.H., Marie J.C., Dichek D.A. TGF-β1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1251-1257.
19. Gomez D., Al Haj Zen A., Borges L.F., Philippe M., Gutierrez P.S., Jondeau G., Michel J.B., Vranckx R. Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway. J. Pathol. 2009, 218:131-142.
20. Goumans M.J., Liu Z., ten Dijke P. TGF-β signaling in vascular biology and dysfunction. Cell Res. 2009, 19:116-127.
21. Goumans M.J., Mummery C. Functional analysis of the TGFβ receptor/Smad pathway through gene ablation in mice. Int. J. Dev. Biol. 2000, 44:253-265.
22. Guo D.C., Pannu H., Tran-Fadulu V., Papke C.L., Yu R.K., Avidan N., Bourgeois S., Estrera A.L., Safi H.J., Sparks E., Amor D., Ades L., McConnell V., Willoughby C.E., Abuelo D., Willing M., Lewis R.A., Kim D.H., Scherer S., Tung P.P., Ahn C., Buja L.M., Raman C.S., Shete S.S., Milewicz D.M. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat. Genet. 2007, 39:1488-1493. Erratum in: (2008) Nat. Genet. 40: 255.
23. Habashi J.P., Judge D.P., Holm T.M., Cohn R.D., Loeys B.L., Cooper T.K., Myers L., Klein E.C., Liu G., Calvi C., Podowski M., Neptune E.R., Halushka M.K., Bedja D., Gabrielson K., Rifkin D.B., Carta L., Ramirez F., Huso D.L., Dietz H.C. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006, 312:117-121.
24. Hanada K., Vermeij M., Garinis G.A., de Waard M.C., Kunen M.G., Myers L., Maas A., Duncker D.J., Meijers C., Dietz H.C., Kanaar R., Essers J. Perturbations of vascular homeostasis and aortic valve abnormalities in fibulin-4 deficient mice. Circ. Res. 2007, 100:738-746.
25. Huang J., Davis E.C., Chapman S.L., Budatha M., Marmorstein L.Y., Word R.A., Yanagisawa H. Fibulin-4 deficiency results in ascending aortic aneurysms: a potential link between abnormal smooth muscle cell phenotype and aneurysm progression. Circ. Res. 2010, 106:583-592.
26. Hynes R.O. The extracellular matrix: not just pretty fibrils. Science 2009, 326:1216-1219.
27. Isogai Z., Ono R.N., Ushiro S., Keene D.R., Chen Y., Mazzieri R., Charbonneau N.L., Reinhardt D.P., Rifkin D.B., Sakai L.Y. Latent transforming growth factor β-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J. Biol. Chem. 2003, 278:2750-2757.
28. Jones J.A, Spinale F.G., Ikonomidis J.S. Transforming growth factor-β signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. J. Vasc. Res. 2009, 46:119-137.
29. Lan Y., Liu B., Yao H., Li F., Weng T., Yang G., Li W., Cheng X., Mao N., Yang X. Essential role of endothelial Smad4 in vascular remodeling and integrity. Mol. Cell Biol. 2007, 27:7683-7692.
30. Loeys B., De Paepe A. New insights in the pathogenesis of aortic aneurysms. Verh. K. Acad. Geneeskd. Belg. 2008, 70:69-84.
31. Loeys B.L., Chen J., Neptune E.R., Judge D.P., Podowski M., Holm T., Meyers J., Leitch C.C., Katsanis N., Sharifi N., Xu F.L., Myers L.A., Spevak P.J., Cameron D.E., De Backer J., Hellemans J., Chen Y., Davis E.C., Webb C.L., Kress W., Coucke P., Rifkin D.B., De Paepe A.M., Dietz H.C. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 2005, 37:275-281.
32. Loeys B.L., Schwarze U., Holm T., Callewaert B.L., Thomas G.H., Pannu H., De Backer J.F., Oswald G.L., Symoens S., Manouvrier S., Roberts A.E., Faravelli F., Greco M.A., Pyeritz R.E., Milewicz D.M., Coucke P.J., Cameron D.E., Braverman A.C., Byers P.H., De Paepe A.M., Dietz H.C. Aneurysm syndromes caused by mutations in the TGF-β receptor. N. Engl. J. Med. 2006, 355:788-798.
33. Matt P., Habashi J., Carrel T., Cameron D.E., Van Eyk J.E., Dietz H.C. Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan?. J. Thorac. Cardiovasc. Surg. 2008, 135:389-394.
34. McLaughlin P.J., Chen Q., Horiguchi M., Starcher B.C., Stanton J.B., Broekelmann T.J., Marmorstein A.D., McKay B., Mecham R., Nakamura T., Marmorstein L.Y. Targeted disruption of fibulin-4 abolishes elastogenesis and causes perinatal lethality in mice. Mol. Cell Biol. 2006, 26:1700-1709.
35. Milewicz D.M., Guo D.C., Tran-Fadulu V., Lafont A.L., Papke C.L., Inamoto S., Kwartler C.S., Pannu H. Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. Annu. Rev. Genomics Hum. Genet. 2008, 9:283-302.
36. Mizuguchi T., Collod-Beroud G., Akiyama T., Abifadel M., Harada N., Morisaki T., Allard D., Varret M., Claustres M., Morisaki H., Ihara M., Kinoshita A., Yoshiura K., Junien C., Kajii T., Jondeau G., Ohta T., Kishino T., Furukawa Y., Nakamura Y., Niikawa N., Boileau C., Matsumoto N. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat. Genet. 2004, 36:855-860.
37. Moustakas A., Souchelnytskyi S., Heldin C.H. Smad regulation in TGF-β signal transduction. J. Cell Sci. 2001, 114:4359-4369.
38. Neptune E.R., Frischmeyer P.A., Arking D.E., Myers L., Bunton T.E., Gayraud B., Ramirez F., Sakai L.Y., Dietz H.C. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 2003, 33:407-411.
39. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84:767-801.
40. Pannu H., Fadulu V.T., Chang J., Lafont A., Hasham S.N., Sparks E., Giampietro P.F., Zaleski C., Estrera A.L., Safi H.J., Shete S., Willing M.C., Raman C.S., Milewicz D.M. Mutations in transforming growth factor-β receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 2005, 112:513-520.
41. Pannu H., Tran-Fadulu V., Papke C.L., Scherer S., Liu Y., Presley C., Guo D., Estrera A.L., Safi H.J., Brasier A.R., Vick G.W., Marian A.J., Raman C.S., Buja L.M., Milewicz D.M. MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum. Mol. Genet. 2007, 16:2453-2462.
42. Park S.O., Lee Y.J., Seki T., Hong K.H., Fliess N., Jiang Z., Park A., Wu X., Kaartinen V., Roman B.L., Oh S.P. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood 2008, 111:633-642.
43. Rodríguez-Vita J., Sánchez-López E., Esteban V., Rupérez M., Egido J., Ruiz-Ortega M. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-β-independent mechanism. Circulation 2005, 111:2509-2517.
44. Ruiz-Ortega M., Rodríguez-Vita J., Sanchez-Lopez E., Carvajal G., Egido J. TGF-β signaling in vascular fibrosis. Cardiovasc. Res. 2007, 74:196-206.
45. Tang Y., Lee K.S., Yang H., Logan D.W., Wang S., McKinnon M.L., Holt L.J., Condie A., Luu M.T., Akhurst R.J. Epistatic interactions between modifier genes confer strain-specific redundancy for Tgfb1 in developmental angiogenesis. Genomics 2005, 85:60-70.
46. ten Dijke P., Arthur H.M. Extracellular control of TGFβ signaling in vascular development and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:857-869.
47. Tian M., Schiemann W.P. The TGF-β paradox in human cancer: an update. Future Oncol. 2009, 5:259-271.
48. Vorp D.A., Vande Geest J.P. Biomechanical determinants of abdominal aortic aneurysm rupture. Aterioscler. Thromb. Vasc. Biol. 2005, 25:1558-1566.
49. Wang W., Huang X.R., Canlas E., Oka K., Truong L.D., Deng C., Bhowmick N.A., Ju W., Bottinger E.P., Lan H.Y. Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circ. Res. 2006, 98:1032-1039.
50. Wang Y., Ait-Oufella H., Herbin O., Bonnin P., Ramkhelawon B., Taleb S., Huang J., Offenstadt G., Combadière C., Rénia L., Johnson J.L., Tharaux P.L., Tedgui A., Mallat Z. TGF-β activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J. Clin. Invest. 2010, 120:422-432.
51. Zeller J.L., Burke A.E., Glass R.M. JAMA patient page. Aortic aneurysms. JAMA 2009, 302:2050.
52. Zhu L., Vranckx R., Khau Van Kien P., Lalande A., Boisset N., Mathieu F., Wegman M., Glancy L., Gasc J.M., Brunotte F., Bruneval P., Wolf J.E., Michel J.B., Jeunemaitre X. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat. Genet. 2006, 38:343-349.